CymitQuimica logo

Pamiparib

CAS:

Ref. 3D-BP180190

25mg
473.00€
50mg
701.00€
100mg
1,002.00€
250mg
1,254.00€
500mg
1,954.00€
Pamiparib
Biosynth

Product Information

Name:Pamiparib
Controlled Product
Synonyms:
  • Pamiparib BGB-290 BGB 290 BGB290
Brand:Biosynth
Description:Pamiparib is a drug that is used to treat breast cancer and other solid tumours. It has been shown to inhibit the activity of the P-glycoprotein (P-gp) transporter, which prevents the escape of anticancer drugs from cells, resulting in increased concentrations of these drugs in tumour tissues. Pamiparib binds to the PDGFR-β receptor, inhibiting the growth factor epidermal growth factor (EGF). Pamiparib has been shown to be effective on resistant prostate cancer cells with high levels of EGF receptors. This drug also inhibits adenosine diphosphate ribose (ADPR) synthesis and platinum-based chemotherapy, as well as radiation therapy. The pharmacokinetic properties of pamiparib have been shown through plasma concentration–time curves for a single dose and multiple doses over time.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:298.32 g/mol
Formula:C16H15FN4O
Purity:Min. 95%

Technical inquiry about: Pamiparib

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.